7月 2026
- 首頁
- Sucampo Pharmaceuticals
7月 2026Sucampo Pharmaceuticals的市場佔有率分析
An essential part of our mission is to improve lives. So we’re shining a spotlight on a few of our patients and their families inspiring stories.
Sucampo Pharmaceuticals(包含公司地區)
查看更多網站流量與參與度資訊- sucampo.com
Sucampo Pharmaceuticals截至 7月 2026 的總收入為 200M - 500M
Sucampo Pharmaceuticals 熱門網域產生的總收入
Sucampo Pharmaceuticals 熱門網域 3 年內的總收入
Sucampo Pharmaceuticals 熱門網域的總收入
Sucampo Pharmaceuticals的熱門網域總造訪量
了解Sucampo Pharmaceuticals市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
Sucampo Pharmaceuticals的熱門網域平均造訪時長
分析Sucampo Pharmaceuticals參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
Sucampo Pharmaceuticals的熱門網域平均頁面瀏覽量
了解Sucampo Pharmaceuticals如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Sucampo Pharmaceuticals
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Sucampo Pharmaceuticals, Inc. partnered with Takeda Pharmaceuticals on Jul 1st '06.The case centered on Amitiza, a medication developed by Sucampo Pharmaceuticals, which partnered with Takeda to market the drug in the United States after its approval in 2006.
5月 19, 2026閱讀更多
新聞Takeda Pharmaceuticals ended partnership with Sucampo Pharmaceuticals, Inc. on Mar 31st '24.Takeda's collaboration and license agreement with Sucampo related to AMITIZA was terminated as of March 31, 2024, and Takeda no longer sells or markets AMITIZA.
5月 19, 2026閱讀更多
新聞Sucampo Pharmaceuticals, Inc. partnered with Dr. Reddy’s Laboratories Ltd. on Jan 20th '21.The Sucampo Pharmaceuticals, Inc. also partnered with Par Pharmaceuticals, Inc. and Dr. Reddy’s Laboratories Ltd.
3月 31, 2021閱讀更多
查看所有Sucampo Pharmaceuticals信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
